Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial

scientific article published on 02 September 2019

Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41598-019-49159-0
P932PMC publication ID6718409
P698PubMed publication ID31477748

P50authorKyoung Yul SeoQ41489571
Ikhyun JunQ63809160
P2093author name stringEung Kweon Kim
Hyung Keun Lee
Tae-Im Kim
Young Joon Choi
Geun Young Lee
Seonghee Choi
P2860cites workInvestigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgeryQ33299675
Blinking is controlled primarily by ocular surface conditionsQ34432436
The international workshop on meibomian gland dysfunction: report of the diagnosis subcommitteeQ34769313
Incidence and pattern of dry eye after cataract surgeryQ35050334
Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled studyQ35532014
Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.Q35629673
The course of dry eye after phacoemulsification surgeryQ35677672
Transient Tear Film Dysfunction after Cataract Surgery in Diabetic PatientsQ35895017
Internal spherical aberration by ray tracing-type aberrometry in multifocal pseudophakic eyesQ36238327
The effect of topical cyclosporine 0.05% on dry eye after cataract surgeryQ36872338
Topical diquafosol for patients with obstructive meibomian gland dysfunctionQ36876737
Ocular preservatives: associated risks and newer optionsQ37510923
Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized studyQ37718817
The international workshop on meibomian gland dysfunction: executive summaryQ37859542
Diquafosol ophthalmic solution for dry eye treatmentQ38030453
Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trialsQ38440413
Mechanisms and management of dry eye in cataract surgery patientsQ38633907
TFOS DEWS II Diagnostic Methodology reportQ38652978
Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgeryQ40570672
Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trialsQ42283332
Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunctionQ42732950
Localization of ocular P2Y2 receptor gene expression by in situ hybridizationQ44489521
Contact lens wear is associated with decrease of meibomian glandsQ46149231
Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.Q46213404
Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled TrialQ47936385
Meibomian gland dysfunction and tear cytokines after cataract surgery according to preoperative meibomian gland status.Q48473638
Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled with Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study.Q50063072
Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.Q50603560
Increase in tear film lipid layer thickness after instillation of 3% diquafosol ophthalmic solution in healthy human eyes.Q50760492
Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery.Q50880549
Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation.Q51762558
The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.Q51766966
Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation.Q52250855
Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.Q53328538
The function and morphology of Meibomian glands in patients with thyroid eye disease: a preliminary study.Q53684503
Evaluation of dry eye and meibomian gland dysfunction after cataract surgeryQ87342776
Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eyeQ87957795
Perioperative Ocular Parameters Associated With Persistent Dry Eye Symptoms After Cataract SurgeryQ88067683
The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract SurgeryQ89130256
P433issue1
P921main subjecteye diseaseQ3041498
P304page(s)12659
P577publication date2019-09-02
P1433published inScientific ReportsQ2261792
P1476titleEffects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial
P478volume9

Search more.